Control of the biodegradation rate of poly(DL-lactide) microparticles intended as chemoembolization materials

Journal of Controlled Release

Volumn 38, Issue 2-3, 1996, Pages 109-122

  Grandfils, C ^a   Flandroy, P ^b   Jerome R ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Chemoembolization; Degradation; Microencapsulation; Microparticle; Poly(DL lactide); Solvent evaporation method

Indexed keywords

MICROSPHERE; MOWIOL VP 3 83; POLYLACTIDE; POLYMER; POLYVINYL ALCOHOL; RESOMER 104; RESOMER 206; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL EMBOLISM; BIODEGRADATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; EMULSION; EVAPORATION; HYDROLYSIS; KINETICS; MOLECULAR WEIGHT; PHARMACEUTICS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

EID: 0029921789     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(95)00102-6     Document Type: Article

References (24)

1. T. Kato, R. Nemoto, H. Mori, M. Takahashi and M. Harada, Arterial chemoembolization with mitomycin C microcapsules in the treatment of primary or secondary carcinoma of the kidney, liver, bone and intrapelvic organ, Cancer 48 (1981) 674-680.
2. J.P. Benoit, P. Couvreur, J.P. Devissaguet, H. Fessi, F. Puisieux and L. Roblot-Treupel, Les formes vectorialisées ou à distribution modulée, nouveau systèmes d'administration des médicaments, J. Pharm. Belg. 41 (1986) 319-329.
3. P. Flandroy, C. Grandfils and R. Jérôme, Clinical applications of microspheres in embolizalion and chemoembolization; a comprehensive review and perspectives, in: A. Rolland (Ed.), Pharmaceutical Particulate Carriers in Medical Applications, Vol. 61, Marcel Dekker, New York., 1993, pp. 321-366.
4. P. Madoule, P. Trampont and A. Roche, Chemoembolization: principles and perspectives, J. Microencapsul. 1 (1984) 21-25.
5. T. Ichihara, K. Sakamoto, K. Mori and M. Akagi, Transcatheter arterial chemoembolization therapy for hepatocellular carcinoma using polylactic acid microspheres containing aclarubicin hydrochloride, Cancer Res. 49 (1989) 4357-4362.
6. K. Juni, J. Ogata, M. Nakano, T. Ichihara, K. Mori and M. Akagi, Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing doxorubicin, Chem. Pharm. Bull. 33 (1985) 313-318.
7. G. Spenlehauer, M. Veillard and J.-P. Benoit, Formation and characterization of Cisplatin loaded poly(d,1)lactide microspheres for chemoembolization, J. Pharm. Sci. 75 (8) (1986) 750-755.
8. G. Spenlehauer, M. Vert, J.P. Benoit, F. Chabot and M. Veillard, Biodegradation cisplatin microspheres prepared by the solvent evaporation method: morphology and release charcteristics, J. Control. Release 7 (1988) 217-229.
9. G.E. Visscher, R.L. Robison, H.V. Maulding, J.W. Fong, J.E. Pearson and G.J. Argentieri, Biodegradation of and tissue reaction to poly( DL-lactide) microcapsules, J. Biomed. Mater. Res. 20 (1986) 667-676.
10. H.V. Maulding, T.R. Tice, D.R. Cowsar, J.W. Fong, J.E. Pearson and J.P. Nazareno, Biodegradable microcapsules: acceleration of polymeric excipient. Hydrolytic rate by incorporation of a basic medicament, J. Control. Release 3 (1986) 103-117.
11. Y. Cha and C.G. Pitt, The acceleration of degradation-controlled drug delivery from polyester microspheres, J. Control. Release 8 (1989) 259-265.
12. R. Bodmeier, K.H. Oh and H. Chen, The effect of the addition of low molecular weight poly ( DL-lactide ) on drug release from biodegradable poly (DL-lactide) drug delivery systems, Int. J. Pharm. 51 (1989) 1-8.
13. C. Grandfils, P. Flandroy, N. Nihant, S. Barbette, R. Jérôme and P. Teyssié. Preparation of poly(DL)lactide microspheres and their clinical applications as a convenient embolic material, J. Biomed. Mater. Res. 26 (1992) 467-479.
14. J.A.P.P. Van Dijk and J.A.M. Smit, Characterization of poly(DL-lactic acid) by gel permeation chromatography, J. Pharm. Sci. 21 (1983) 197-208.
15. T. St. Pierre and E. Chiellini, Biodegradability of synthetic polymers used for medical and pharmaceutical applications: part 1 - principles of hydrolysis mechanisms, J. Bioact. Compat. Polym. 1 (1986) 467-497.
16. M. Vert, S. Li and H. Garreau, More about the degradation of LA/GA-derived matrices in aqueous media. J. Control. Release 16 (1991) 15-26.
17. S. Li and M. Vert, Crystalline oligomeric stereocomplex as an intermediate compound in racemic poly(DL-lactic acid) degradation, Polym. Int. 33 (1994) 37-41.
18. B. Wiehert and P. Rohdewald, A new method for the preparation of drug containing polylactic acid microparticles without using organic solvents, J. Control. Release 14 (1990) 269-283.
19. A. Celli and M. Scandola, Thermal properties and physical ageing of poly(L-lactic acid), Polymer 33 (1992) 2699-2703.
20. S. Harley, D.W. Thompson and B. Vincent, The adsorption of small particles onto larger particles of opposite charge. Direct electron microscope studies, Colloids Surfaces 62 (1992) 163-176.
21. S.S. Shah, Y. Cha and C.G. Pitt, Poly(glycolic acid-co-DL-lactic acid) - Diffusion or degradation controlled drug delivery, J. Control. Release 18 (1992) 261-270.
22. G. Spenlehauer, M. Vert, J.P. Benoît and A. Boddaert, In vitro and in vivo degradation of poly(DL)lactide/glycolide type microspheres made by solvent evaporation method, Biomaterials 10 (1989) 557-563.
23. K. Makino, H. Ohshima and T. Kondo, Mechanism of hydrolytic degradation of poly(L-lactide) microcapsules: effect of pH, ionic strength and buffer concentration, J. Microencapsul. 3 (1986) 203-212.
24. R.A. Kenley, M.O. Lee, T.R. Mahoney and L.M. Sanders, Poly (lactide-co-glycolide) decomposition kinetics in vivo and in vitro, Macromolecules 20 (1987) 2398-2403.